ArticleJournal of personalized medicine2024

Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers.

Stefano Gentileschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.